BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 17577784)

  • 1. Expression and mutation analysis of genes that encode the Myc antagonists Mad1, Mxi1 and Rox in acute leukaemia.
    Guo XL; Pan L; Zhang XJ; Suo XH; Niu ZY; Zhang JY; Wang F; Dong ZR; Da W; Ohno R
    Leuk Lymphoma; 2007 Jun; 48(6):1200-7. PubMed ID: 17577784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Expression and mutation of myc antagonist genes Mad1, Mxi1 and Rox in leukemia cells].
    Suo XH; Pan L; Yao L; Zhang XJ; Niu ZY; Dong ZR
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):745-9. PubMed ID: 18457265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rox, a novel bHLHZip protein expressed in quiescent cells that heterodimerizes with Max, binds a non-canonical E box and acts as a transcriptional repressor.
    Meroni G; Reymond A; Alcalay M; Borsani G; Tanigami A; Tonlorenzi R; Lo Nigro C; Messali S; Zollo M; Ledbetter DH; Brent R; Ballabio A; Carrozzo R
    EMBO J; 1997 May; 16(10):2892-906. PubMed ID: 9184233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
    Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of Mxi1-SR alpha by FOXO3a contributes to repression of Myc-dependent gene expression.
    Delpuech O; Griffiths B; East P; Essafi A; Lam EW; Burgering B; Downward J; Schulze A
    Mol Cell Biol; 2007 Jul; 27(13):4917-30. PubMed ID: 17452451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and subcellular localization of the Myc superfamily proteins: c-Myc, Max, Mad1 and Mxi1 in the epiphyseal plate cartilage chondrocytes of growing rats.
    Wang Y; Toury R; Hauchecorne M; Balmain N
    Cell Mol Biol (Noisy-le-grand); 1997 Mar; 43(2):175-88. PubMed ID: 9130602
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mad1 expression in the absence of differentiation: effect of cAMP on the B-lymphoid cell line Reh.
    Naderi S; Blomhoff HK
    J Cell Physiol; 1999 Jan; 178(1):76-84. PubMed ID: 9886493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mlx, a new Max-like bHLHZip family member: the center stage of a novel transcription factors regulatory pathway?
    Meroni G; Cairo S; Merla G; Messali S; Brent R; Ballabio A; Reymond A
    Oncogene; 2000 Jul; 19(29):3266-77. PubMed ID: 10918583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. An amino-terminal domain of Mxi1 mediates anti-Myc oncogenic activity and interacts with a homolog of the yeast transcriptional repressor SIN3.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Rao G; Guida P; Skoultchi AI; DePinho RA
    Cell; 1995 Mar; 80(5):777-86. PubMed ID: 7889571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mad proteins contain a dominant transcription repression domain.
    Ayer DE; Laherty CD; Lawrence QA; Armstrong AP; Eisenman RN
    Mol Cell Biol; 1996 Oct; 16(10):5772-81. PubMed ID: 8816491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolutionary relationships and functional conservation among vertebrate Max-associated proteins: the zebra fish homolog of Mxi1.
    Schreiber-Agus N; Chin L; Chen K; Torres R; Thomson CT; Sacchettini JC; DePinho RA
    Oncogene; 1994 Nov; 9(11):3167-77. PubMed ID: 7936639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mxi1 is a potential cellular target of carcinogens and frequently mutated in experimental rat tumors and tumor cell lines.
    Wang DY; Xiang YY; Li XJ; Hashimoto M; Tanaka M; Sugimura H
    Pathol Int; 2000 May; 50(5):373-83. PubMed ID: 10849326
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of Mxi1 inhibits the induction of the human ornithine decarboxylase gene by the Myc/Max protein complex.
    Wu S; Peña A; Korcz A; Soprano DR; Soprano KJ
    Oncogene; 1996 Feb; 12(3):621-9. PubMed ID: 8637719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the MYC antagonist MAD1 inhibits cell cycle exit during granulocyte differentiation.
    Foley KP; McArthur GA; Quéva C; Hurlin PJ; Soriano P; Eisenman RN
    EMBO J; 1998 Feb; 17(3):774-85. PubMed ID: 9451002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mxi1, a protein that specifically interacts with Max to bind Myc-Max recognition sites.
    Zervos AS; Gyuris J; Brent R
    Cell; 1993 Jan; 72(2):223-32. PubMed ID: 8425219
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression by the Mad(Mxi1)-Sin3 complex.
    Schreiber-Agus N; DePinho RA
    Bioessays; 1998 Oct; 20(10):808-18. PubMed ID: 9819568
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic in vivo interactions among Myc network members.
    Yin X; Landay MF; Han W; Levitan ES; Watkins SC; Levenson RM; Farkas DL; Prochownik EV
    Oncogene; 2001 Aug; 20(34):4650-64. PubMed ID: 11498788
    [TBL] [Abstract][Full Text] [Related]  

  • 20. c-Myc and Mxi1 immunoreactivities in the calcifying areas of the epiphyseal-plate cartilage matrix of growing rats.
    Toury R; Wang Y; Hauchecorne M; Balmain N
    Bone; 1999 Jun; 24(6):555-63. PubMed ID: 10375197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.